Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate
Objective Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the develo...
Saved in:
Published in | Hormones (Athens, Greece) Vol. 17; no. 2; pp. 237 - 246 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.06.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 1109-3099 2520-8721 2520-8721 |
DOI | 10.1007/s42000-018-0022-8 |
Cover
Loading…
Abstract | Objective
Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT).
Design
Serum 25(OH)D, 1,25(OH)
2
D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m
2
. Participants were categorized according to eGFR (ml/min/1.73m
2
): G1 ≥ 60 (
n
= 53), G2 30–59 (
n
= 35), and G3 15–29 (
n
= 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (
n
= 23), G2-nw (
n
= 18), and G3-nw (
n
= 9).
Results
25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml,
p
= 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml,
p
= 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml,
p
= 0.030). 1,25(OH)
2
D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m
2
, lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m
2
.
Conclusions
Lower serum 25(OH)D but similar 1,25(OH)
2
D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined. |
---|---|
AbstractList | Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT).
Serum 25(OH)D, 1,25(OH)
D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m
. Participants were categorized according to eGFR (ml/min/1.73m
): G1 ≥ 60 (n = 53), G2 30-59 (n = 35), and G3 15-29 (n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (n = 23), G2-nw (n = 18), and G3-nw (n = 9).
25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH)
D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m
, lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m
.
Lower serum 25(OH)D but similar 1,25(OH)
D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined. Objective Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT). Design Serum 25(OH)D, 1,25(OH) 2 D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m 2 . Participants were categorized according to eGFR (ml/min/1.73m 2 ): G1 ≥ 60 ( n = 53), G2 30–59 ( n = 35), and G3 15–29 ( n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw ( n = 23), G2-nw ( n = 18), and G3-nw ( n = 9). Results 25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH) 2 D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m 2 , lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m 2 . Conclusions Lower serum 25(OH)D but similar 1,25(OH) 2 D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined. Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT).OBJECTIVEObesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT).Serum 25(OH)D, 1,25(OH)2D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m2. Participants were categorized according to eGFR (ml/min/1.73m2): G1 ≥ 60 (n = 53), G2 30-59 (n = 35), and G3 15-29 (n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (n = 23), G2-nw (n = 18), and G3-nw (n = 9).DESIGNSerum 25(OH)D, 1,25(OH)2D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m2. Participants were categorized according to eGFR (ml/min/1.73m2): G1 ≥ 60 (n = 53), G2 30-59 (n = 35), and G3 15-29 (n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (n = 23), G2-nw (n = 18), and G3-nw (n = 9).25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH)2D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m2, lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m2.RESULTS25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH)2D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m2, lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m2.Lower serum 25(OH)D but similar 1,25(OH)2D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined.CONCLUSIONSLower serum 25(OH)D but similar 1,25(OH)2D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined. |
Author | Tigas, Stelios Siamopoulos, Kostas C. Kalaitzidis, Rigas Dounousi, Evangelia Challa, Anna Kitsos, Athanasios |
Author_xml | – sequence: 1 givenname: Athanasios surname: Kitsos fullname: Kitsos, Athanasios organization: Department of Nephrology, University of Ioannina – sequence: 2 givenname: Evangelia surname: Dounousi fullname: Dounousi, Evangelia organization: Department of Nephrology, University of Ioannina – sequence: 3 givenname: Rigas surname: Kalaitzidis fullname: Kalaitzidis, Rigas organization: Department of Nephrology, University of Ioannina – sequence: 4 givenname: Anna surname: Challa fullname: Challa, Anna organization: Pediatric Research Laboratory, Child Health Department, University of Ioannina – sequence: 5 givenname: Kostas C. surname: Siamopoulos fullname: Siamopoulos, Kostas C. organization: Department of Nephrology, University of Ioannina – sequence: 6 givenname: Stelios surname: Tigas fullname: Tigas, Stelios email: stigas@cc.uoi.gr organization: Department of Endocrinology, University of Ioannina |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29858844$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMFOHSEUQEljU5-2H9CNYelm7AWGGVgata2JSRd1TxjmzisvM6DAaPr35eVpFy7ccDfnXOCckKMQAxLylcEFA-i_5ZYDQANMNQCcN-oD2XDJoVE9Z0dkwxjoRoDWx-Qk5x1AJ7Vin8gx10oq1bYbMvzGtC70yRe7-ECvaT3igBmpDSONT5ie0W__FJrXYYeuZGqdi2n0YUtLpJiLX2zBkW7nuNRVs0108nNJtvgYaB34mXyc7Jzxy8s8Jfffb-6vfjZ3v37cXl3eNU6ovjRDJwHcNMI4TKwXGpllzGmhu0nL0YLiHQolreCql1ZZoa2SjCkOA29xEKfk_LD2IcXHtT7MLD47nGcbMK7ZcGi17EBwXdGzF3QdFhzNQ6qfSH_Na5YKsAPgUsw54fQfYWD26c0hvanpzT69UdXp3ziuRt1XqDH8_K7JD2aut4QtJrOLawq11TvSP_iTl50 |
CitedBy_id | crossref_primary_10_1177_2333794X211018352 crossref_primary_10_3389_fped_2021_696942 |
Cites_doi | 10.1373/clinchem.2012.193003 10.2337/dc10-S062 10.1159/000098561 10.1053/j.ajkd.2014.05.018 10.1210/jc.2010-2704 10.1210/jc.2003-031398 10.1046/j.1523-1755.1999.0550031019.x 10.1053/j.ajkd.2007.04.010 10.1210/jc.2010-0757 10.1053/j.ajkd.2011.12.035 10.1016/j.kisu.2017.04.001 10.1093/ndt/gft360 10.14310/horm.2002.1674 10.1515/hmbci-2015-0069 10.1053/j.jrn.2014.04.005 10.5414/CN108182 10.1053/j.jrn.2013.07.003 10.1007/BF03349258 10.1186/1752-153X-6-112 10.1016/j.nut.2016.06.012 10.1161/HYPERTENSIONAHA.114.03748 10.3390/nu5030949 10.7326/0003-4819-130-6-199903160-00002 10.1093/ajcn/86.4.959 10.1159/000441364 10.1186/1475-2840-11-149 10.3945/ajcn.115.120139 10.1038/sj.ki.5002009 10.1210/jc.2011-0385 |
ContentType | Journal Article |
Copyright | Hellenic Endocrine Society 2018 |
Copyright_xml | – notice: Hellenic Endocrine Society 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s42000-018-0022-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 2520-8721 |
EndPage | 246 |
ExternalDocumentID | 29858844 10_1007_s42000_018_0022_8 |
Genre | Journal Article |
GroupedDBID | --- -EM 0R~ 406 53G AAAVM AACDK AAHNG AAIAL AAJBT AASML AATNV AAUYE ABAKF ABDZT ABECU ABFTV ABJNI ABKCH ABMQK ABQBU ABTEG ABTKH ABTMW ABXPI ACAOD ACDTI ACGFS ACHSB ACMLO ACOKC ACPIV ACZOJ ADBBV ADKNI ADRFC ADTPH ADURQ ADYFF AEFQL AEJRE AEMSY AEOHA AESKC AFBBN AFQWF AGDGC AGJBK AGMZJ AGQEE AGRTI AIAKS AIGIU AILAN AITGF AJZVZ ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR AXYYD BAWUL BGNMA CSCUP DIK DPUIP EBLON EBS EJD F5P FIGPU FINBP FNLPD FRP FSGXE GGCAI HG6 IKXTQ IWAJR J-C JZLTJ LLZTM M4Y NPVJJ NQJWS NU0 O9J OK1 PT4 RLLFE ROL RSV SISQX SJYHP SNE SNPRN SOHCF SOJ SPISZ SRMVM SSLCW STPWE SV3 TR2 TSG UOJIU UTJUX UZXMN VFIZW ZMTXR AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 ABRTQ |
ID | FETCH-LOGICAL-c387t-b6500cfd0dbf1739e1a11c9396f95da0826e385a32875a8a39a8511820b24eb3 |
ISSN | 1109-3099 2520-8721 |
IngestDate | Thu Sep 04 15:25:46 EDT 2025 Wed Feb 19 02:42:42 EST 2025 Tue Jul 01 03:52:04 EDT 2025 Thu Apr 24 22:55:04 EDT 2025 Fri Feb 21 02:34:59 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Obesity Vitamin D D PTH 25(OH)D 1,25(OH) Chronic kidney disease Secondary hyperparathyroidism 1,25(OH)2D |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c387t-b6500cfd0dbf1739e1a11c9396f95da0826e385a32875a8a39a8511820b24eb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://link.springer.com/content/pdf/10.1007/s42000-018-0022-8.pdf |
PMID | 29858844 |
PQID | 2049560329 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2049560329 pubmed_primary_29858844 crossref_primary_10_1007_s42000_018_0022_8 crossref_citationtrail_10_1007_s42000_018_0022_8 springer_journals_10_1007_s42000_018_0022_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20180600 2018-6-00 2018-Jun 20180601 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 6 year: 2018 text: 20180600 |
PublicationDecade | 2010 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Switzerland |
PublicationSubtitle | International Journal of Endocrinology and Metabolism |
PublicationTitle | Hormones (Athens, Greece) |
PublicationTitleAbbrev | Hormones |
PublicationTitleAlternate | Hormones (Athens) |
PublicationYear | 2018 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | GuessousIMcClellanWKleinbaumDComparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based studyJ Ren Nutr201424530331210.1053/j.jrn.2014.04.005250302231:CAS:528:DC%2BC2cXhtFGmtbnO LundwallKJorneskogGJacobsonSHSpaakJParicalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trialAm J Nephrol201542426527310.1159/000441364264962101:CAS:528:DC%2BC2MXhvFKhs7%2FL EknoyanGObesity and chronic kidney diseaseNefrologia2011314397403216233931:STN:280:DC%2BC3Mjot1aitQ%3D%3D HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab20119671911193010.1210/jc.2011-0385216463681:CAS:528:DC%2BC3MXptlSku7o%3D LeveyASBoschJPLewisJBGreeneTRogersNRothDA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med 161999130646147010.7326/0003-4819-130-6-199903160-000021:CAS:528:DyaK1MXitFChs7k%3D SergeevIN1,25-Dihydroxyvitamin D3 and type 2 diabetes: Ca2+−dependent molecular mechanisms and the role of vitamin D statusHorm Mol Biol Clin Investig20162616165268768151:CAS:528:DC%2BC28XpsFGqurc%3D TzotzasTPapadopoulouFGTziomalosKRising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistanceJ Clin Endocrinol Metab20109594251425710.1210/jc.2010-0757205347511:CAS:528:DC%2BC3cXht1Wms7zJ National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392 Suppl 1S1 NigwekarSUBhanIThadhaniRErgocalciferol and cholecalciferol in CKDAm J Kidney Dis201260113915610.1053/j.ajkd.2011.12.035225608321:CAS:528:DC%2BC38Xmslyhu7w%3D PapapetrouPDTriantafyllopoulouMKorakovouniASevere vitamin D deficiency in the institutionalized elderlyJ Endocrinol Investig200831978478710.1007/BF033492581:CAS:528:DC%2BC3cXisVGhs70%3D Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation200217, 1062531433421 KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:S1–S59 LevinABakrisGLMolitchMPrevalence of abnormal serum vitamin D, PTH, calcium, and phosphate in patients with chronic kidney disease: results of the study to evaluate early kidney diseaseKidney Int2007711313810.1038/sj.ki.5002009170911241:CAS:528:DC%2BD28XhtlSqtbnK European health interview survey. http://ec.europa.eu/eurostat. Published online October 20, 2016 MolinaPGorrizJLMolinaMDThe effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled studyNephrol Dial Transplant20142919710910.1093/ndt/gft360239758421:CAS:528:DC%2BC2cXmt1yqtg%3D%3D WalshJSEvansALBowlesSFree 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone healthAm J Clin Nutr201610361465147110.3945/ajcn.115.120139271698391:CAS:528:DC%2BC28Xhs1Gis7fN ZismanALHristovaMHoLTSpragueSMImpact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney diseaseAm J Nephrol2007271364310.1159/000098561172155731:CAS:528:DC%2BD2sXisFygsr8%3D NgaiMLinVWongHCVathsalaAHowPVitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease populationClin Nephrol201482423123910.5414/CN108182251611151:CAS:528:DC%2BC2cXitVyltL%2FI RossACMansonJEAbramsSAThe 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to knowJ Clin Endocrinol Metab2011961535810.1210/jc.2010-2704211188271:CAS:528:DC%2BC3MXhtFGntbg%3D Barreto SilvaMICavalieriVVLemosCCKleinMRBregmanRBody adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: a cross-sectional analysis in a tropical climate cityNutrition20173324024710.1016/j.nut.2016.06.012276929901:CAS:528:DC%2BC28Xhs1Sisr%2FK ParikhSJEdelmanMUwaifoGIThe relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adultsJ Clin Endocrinol Metab20048931196119910.1210/jc.2003-031398150016091:CAS:528:DC%2BD2cXisVWrurY%3D World Health Organization 2000 Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series (894). Geneva, Switzerland: WHO. Available at: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en MartinKJGonzálezEAVitamin D supplementation in CKDClin Nephrol2011754286293214268821:CAS:528:DC%2BC3MXntlKgtrw%3D VanlintSVitamin D and obesityNutrients Mar20135394995610.3390/nu50309491:CAS:528:DC%2BC3sXkvVajtL8%3D KatrinakiMKampaMMargiorisACastanasEMalliarakiNVitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off valuesHormones (Athens)201615220522310.14310/horm.2002.1674 American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201033Suppl 1S62S6910.2337/dc10-S0622797383 ShahIPetrocziANaughtonDPMethod for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometryChem Cent J20121;61112 AfzalSBojesenSENordestgaardBGLow 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysisClin Chem201359238139110.1373/clinchem.2012.193003232320641:CAS:528:DC%2BC3sXhvFOgsL8%3D BollandMJGreyABAmesRWThe effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiencyAm J Clin Nutr2007864959642810.1093/ajcn/86.4.959179213711:CAS:528:DC%2BD2sXhtFyks7nO KimSMChoiHJLeeJPPrevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney diseaseJ Ren Nutr2014241202510.1053/j.jrn.2013.07.003242162581:CAS:528:DC%2BC3sXhslGls7jN Al-AlyZQaziRAGonzálezEAZeringueAMartinKJChanges in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKDAm J Kidney Dis2007501596810.1053/j.ajkd.2007.04.010175915251:CAS:528:DC%2BD2sXosVKksrg%3D KramerHBernsJSChoiMJMartinKRoccoMV25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies reportAm J Kidney Dis201464449950910.1053/j.ajkd.2014.05.018250821011:CAS:528:DC%2BC2cXhtlaiurjL LagunovaZPorojnicuALindbergFHexebergSMoanJThe dependency of vitamin D status on body mass index, gender, age and seasonAnticancer Res200929937133720196671691:CAS:528:DC%2BD1MXhtVKku7fF ZoccaliCCuratolaGPanuccioVParicalcitol and endothelial function in chronic kidney disease trialHypertension20146451005101110.1161/HYPERTENSIONAHA.114.03748252597431:CAS:528:DC%2BC2cXhvVSnsrjP IshimuraENishizawaYInabaMSerum levels of 1,25- dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failureKidney Int1999551019102710.1046/j.1523-1755.1999.0550031019.x100279391:STN:280:DyaK1M7lt1ahtw%3D%3D GuaschABullóMRabassaABonadaADel CastilloDSabenchFSalas-SalvadóJPlasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional studyCardiovasc Diabetol2012111114910.1186/1475-2840-11-1492322819835410711:CAS:528:DC%2BC3sXjslCis7s%3D K Lundwall (22_CR10) 2015; 42 AS Levey (22_CR15) 1999; 130 Z Al-Aly (22_CR32) 2007; 50 National Kidney Foundation (22_CR16) 2002; 39 MF Holick (22_CR6) 2011; 96 IN Sergeev (22_CR35) 2016; 26 M Ngai (22_CR25) 2014; 82 M Katrinaki (22_CR21) 2016; 15 Z Lagunova (22_CR5) 2009; 29 AL Zisman (22_CR33) 2007; 27 S Afzal (22_CR34) 2013; 59 22_CR8 22_CR14 E Ishimura (22_CR30) 1999; 55 P Molina (22_CR12) 2014; 29 22_CR1 A Guasch (22_CR22) 2012; 11 Third Report of the National Cholesterol Education Program (NCEP) (22_CR18) 2002; 17, 106 SJ Parikh (22_CR4) 2004; 89 C Zoccali (22_CR11) 2014; 64 I Shah (22_CR24) 2012; 1;6 JS Walsh (22_CR23) 2016; 103 KJ Martin (22_CR31) 2011; 75 S Vanlint (22_CR3) 2013; 5 A Levin (22_CR26) 2007; 71 I Guessous (22_CR28) 2014; 24 PD Papapetrou (22_CR19) 2008; 31 American Diabetes Association (22_CR17) 2010; 33 T Tzotzas (22_CR20) 2010; 95 H Kramer (22_CR9) 2014; 64 AC Ross (22_CR29) 2011; 96 G Eknoyan (22_CR2) 2011; 31 MI Barreto Silva (22_CR13) 2017; 33 MJ Bolland (22_CR36) 2007; 86 SM Kim (22_CR27) 2014; 24 SU Nigwekar (22_CR7) 2012; 60 |
References_xml | – reference: KramerHBernsJSChoiMJMartinKRoccoMV25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies reportAm J Kidney Dis201464449950910.1053/j.ajkd.2014.05.018250821011:CAS:528:DC%2BC2cXhtlaiurjL – reference: BollandMJGreyABAmesRWThe effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiencyAm J Clin Nutr2007864959642810.1093/ajcn/86.4.959179213711:CAS:528:DC%2BD2sXhtFyks7nO – reference: World Health Organization 2000 Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series (894). Geneva, Switzerland: WHO. Available at: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ – reference: KimSMChoiHJLeeJPPrevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney diseaseJ Ren Nutr2014241202510.1053/j.jrn.2013.07.003242162581:CAS:528:DC%2BC3sXhslGls7jN – reference: GuessousIMcClellanWKleinbaumDComparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based studyJ Ren Nutr201424530331210.1053/j.jrn.2014.04.005250302231:CAS:528:DC%2BC2cXhtFGmtbnO – reference: KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:S1–S59 – reference: LundwallKJorneskogGJacobsonSHSpaakJParicalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trialAm J Nephrol201542426527310.1159/000441364264962101:CAS:528:DC%2BC2MXhvFKhs7%2FL – reference: ZismanALHristovaMHoLTSpragueSMImpact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney diseaseAm J Nephrol2007271364310.1159/000098561172155731:CAS:528:DC%2BD2sXisFygsr8%3D – reference: AfzalSBojesenSENordestgaardBGLow 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysisClin Chem201359238139110.1373/clinchem.2012.193003232320641:CAS:528:DC%2BC3sXhvFOgsL8%3D – reference: LagunovaZPorojnicuALindbergFHexebergSMoanJThe dependency of vitamin D status on body mass index, gender, age and seasonAnticancer Res200929937133720196671691:CAS:528:DC%2BD1MXhtVKku7fF – reference: LeveyASBoschJPLewisJBGreeneTRogersNRothDA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med 161999130646147010.7326/0003-4819-130-6-199903160-000021:CAS:528:DyaK1MXitFChs7k%3D – reference: EknoyanGObesity and chronic kidney diseaseNefrologia2011314397403216233931:STN:280:DC%2BC3Mjot1aitQ%3D%3D – reference: Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation200217, 1062531433421 – reference: MolinaPGorrizJLMolinaMDThe effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled studyNephrol Dial Transplant20142919710910.1093/ndt/gft360239758421:CAS:528:DC%2BC2cXmt1yqtg%3D%3D – reference: RossACMansonJEAbramsSAThe 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to knowJ Clin Endocrinol Metab2011961535810.1210/jc.2010-2704211188271:CAS:528:DC%2BC3MXhtFGntbg%3D – reference: ParikhSJEdelmanMUwaifoGIThe relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adultsJ Clin Endocrinol Metab20048931196119910.1210/jc.2003-031398150016091:CAS:528:DC%2BD2cXisVWrurY%3D – reference: HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab20119671911193010.1210/jc.2011-0385216463681:CAS:528:DC%2BC3MXptlSku7o%3D – reference: VanlintSVitamin D and obesityNutrients Mar20135394995610.3390/nu50309491:CAS:528:DC%2BC3sXkvVajtL8%3D – reference: LevinABakrisGLMolitchMPrevalence of abnormal serum vitamin D, PTH, calcium, and phosphate in patients with chronic kidney disease: results of the study to evaluate early kidney diseaseKidney Int2007711313810.1038/sj.ki.5002009170911241:CAS:528:DC%2BD28XhtlSqtbnK – reference: ShahIPetrocziANaughtonDPMethod for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometryChem Cent J20121;61112 – reference: WalshJSEvansALBowlesSFree 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone healthAm J Clin Nutr201610361465147110.3945/ajcn.115.120139271698391:CAS:528:DC%2BC28Xhs1Gis7fN – reference: PapapetrouPDTriantafyllopoulouMKorakovouniASevere vitamin D deficiency in the institutionalized elderlyJ Endocrinol Investig200831978478710.1007/BF033492581:CAS:528:DC%2BC3cXisVGhs70%3D – reference: TzotzasTPapadopoulouFGTziomalosKRising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistanceJ Clin Endocrinol Metab20109594251425710.1210/jc.2010-0757205347511:CAS:528:DC%2BC3cXht1Wms7zJ – reference: American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201033Suppl 1S62S6910.2337/dc10-S0622797383 – reference: IshimuraENishizawaYInabaMSerum levels of 1,25- dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failureKidney Int1999551019102710.1046/j.1523-1755.1999.0550031019.x100279391:STN:280:DyaK1M7lt1ahtw%3D%3D – reference: KatrinakiMKampaMMargiorisACastanasEMalliarakiNVitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off valuesHormones (Athens)201615220522310.14310/horm.2002.1674 – reference: Al-AlyZQaziRAGonzálezEAZeringueAMartinKJChanges in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKDAm J Kidney Dis2007501596810.1053/j.ajkd.2007.04.010175915251:CAS:528:DC%2BD2sXosVKksrg%3D – reference: NgaiMLinVWongHCVathsalaAHowPVitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease populationClin Nephrol201482423123910.5414/CN108182251611151:CAS:528:DC%2BC2cXitVyltL%2FI – reference: National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392 Suppl 1S1 – reference: ZoccaliCCuratolaGPanuccioVParicalcitol and endothelial function in chronic kidney disease trialHypertension20146451005101110.1161/HYPERTENSIONAHA.114.03748252597431:CAS:528:DC%2BC2cXhvVSnsrjP – reference: MartinKJGonzálezEAVitamin D supplementation in CKDClin Nephrol2011754286293214268821:CAS:528:DC%2BC3MXntlKgtrw%3D – reference: GuaschABullóMRabassaABonadaADel CastilloDSabenchFSalas-SalvadóJPlasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional studyCardiovasc Diabetol2012111114910.1186/1475-2840-11-1492322819835410711:CAS:528:DC%2BC3sXjslCis7s%3D – reference: NigwekarSUBhanIThadhaniRErgocalciferol and cholecalciferol in CKDAm J Kidney Dis201260113915610.1053/j.ajkd.2011.12.035225608321:CAS:528:DC%2BC38Xmslyhu7w%3D – reference: European health interview survey. http://ec.europa.eu/eurostat. Published online October 20, 2016 – reference: Barreto SilvaMICavalieriVVLemosCCKleinMRBregmanRBody adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: a cross-sectional analysis in a tropical climate cityNutrition20173324024710.1016/j.nut.2016.06.012276929901:CAS:528:DC%2BC28Xhs1Sisr%2FK – reference: SergeevIN1,25-Dihydroxyvitamin D3 and type 2 diabetes: Ca2+−dependent molecular mechanisms and the role of vitamin D statusHorm Mol Biol Clin Investig20162616165268768151:CAS:528:DC%2BC28XpsFGqurc%3D – ident: 22_CR14 – volume: 59 start-page: 381 issue: 2 year: 2013 ident: 22_CR34 publication-title: Clin Chem doi: 10.1373/clinchem.2012.193003 – volume: 33 start-page: S62 issue: Suppl 1 year: 2010 ident: 22_CR17 publication-title: Diabetes Care doi: 10.2337/dc10-S062 – volume: 27 start-page: 36 issue: 1 year: 2007 ident: 22_CR33 publication-title: Am J Nephrol doi: 10.1159/000098561 – volume: 64 start-page: 499 issue: 4 year: 2014 ident: 22_CR9 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2014.05.018 – volume: 96 start-page: 53 issue: 1 year: 2011 ident: 22_CR29 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-2704 – volume: 39 start-page: S1 issue: 2 Suppl 1 year: 2002 ident: 22_CR16 publication-title: Am J Kidney Dis – volume: 89 start-page: 1196 issue: 3 year: 2004 ident: 22_CR4 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031398 – ident: 22_CR1 – volume: 55 start-page: 1019 year: 1999 ident: 22_CR30 publication-title: Kidney Int doi: 10.1046/j.1523-1755.1999.0550031019.x – volume: 31 start-page: 397 issue: 4 year: 2011 ident: 22_CR2 publication-title: Nefrologia – volume: 50 start-page: 59 issue: 1 year: 2007 ident: 22_CR32 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2007.04.010 – volume: 95 start-page: 4251 issue: 9 year: 2010 ident: 22_CR20 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0757 – volume: 60 start-page: 139 issue: 1 year: 2012 ident: 22_CR7 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2011.12.035 – ident: 22_CR8 doi: 10.1016/j.kisu.2017.04.001 – volume: 29 start-page: 97 issue: 1 year: 2014 ident: 22_CR12 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gft360 – volume: 15 start-page: 205 issue: 2 year: 2016 ident: 22_CR21 publication-title: Hormones (Athens) doi: 10.14310/horm.2002.1674 – volume: 26 start-page: 61 issue: 1 year: 2016 ident: 22_CR35 publication-title: Horm Mol Biol Clin Investig doi: 10.1515/hmbci-2015-0069 – volume: 24 start-page: 303 issue: 5 year: 2014 ident: 22_CR28 publication-title: J Ren Nutr doi: 10.1053/j.jrn.2014.04.005 – volume: 82 start-page: 231 issue: 4 year: 2014 ident: 22_CR25 publication-title: Clin Nephrol doi: 10.5414/CN108182 – volume: 24 start-page: 20 issue: 1 year: 2014 ident: 22_CR27 publication-title: J Ren Nutr doi: 10.1053/j.jrn.2013.07.003 – volume: 75 start-page: 286 issue: 4 year: 2011 ident: 22_CR31 publication-title: Clin Nephrol – volume: 31 start-page: 784 issue: 9 year: 2008 ident: 22_CR19 publication-title: J Endocrinol Investig doi: 10.1007/BF03349258 – volume: 1;6 start-page: 112 issue: 1 year: 2012 ident: 22_CR24 publication-title: Chem Cent J doi: 10.1186/1752-153X-6-112 – volume: 33 start-page: 240 year: 2017 ident: 22_CR13 publication-title: Nutrition doi: 10.1016/j.nut.2016.06.012 – volume: 64 start-page: 1005 issue: 5 year: 2014 ident: 22_CR11 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.03748 – volume: 5 start-page: 949 issue: 3 year: 2013 ident: 22_CR3 publication-title: Nutrients Mar doi: 10.3390/nu5030949 – volume: 130 start-page: 461 issue: 6 year: 1999 ident: 22_CR15 publication-title: Ann Intern Med 16 doi: 10.7326/0003-4819-130-6-199903160-00002 – volume: 17, 106 start-page: 3143 issue: 25 year: 2002 ident: 22_CR18 publication-title: Circulation – volume: 86 start-page: 959 issue: 4 year: 2007 ident: 22_CR36 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/86.4.959 – volume: 42 start-page: 265 issue: 4 year: 2015 ident: 22_CR10 publication-title: Am J Nephrol doi: 10.1159/000441364 – volume: 11 start-page: 149 issue: 11 year: 2012 ident: 22_CR22 publication-title: Cardiovasc Diabetol doi: 10.1186/1475-2840-11-149 – volume: 103 start-page: 1465 issue: 6 year: 2016 ident: 22_CR23 publication-title: Am J Clin Nutr doi: 10.3945/ajcn.115.120139 – volume: 71 start-page: 31 issue: 1 year: 2007 ident: 22_CR26 publication-title: Kidney Int doi: 10.1038/sj.ki.5002009 – volume: 29 start-page: 3713 issue: 9 year: 2009 ident: 22_CR5 publication-title: Anticancer Res – volume: 96 start-page: 1911 issue: 7 year: 2011 ident: 22_CR6 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-0385 |
SSID | ssj0065981 |
Score | 2.1248043 |
Snippet | Objective
Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare... Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 237 |
SubjectTerms | Adolescent Adult Aged Endocrinology Female Glomerular Filtration Rate Humans Hydroxycholecalciferols - blood Hyperparathyroidism, Secondary - blood Male Medicine Medicine & Public Health Metabolic Diseases Middle Aged Obesity - blood Original Article Overweight - blood Parathyroid Hormone - blood Young Adult |
Title | Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate |
URI | https://link.springer.com/article/10.1007/s42000-018-0022-8 https://www.ncbi.nlm.nih.gov/pubmed/29858844 https://www.proquest.com/docview/2049560329 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaW7YULAspjeclIiANRqiTOwzmmLdWKih7QIvUWOY6zSrWbVCSLRMWPZ8bOC5Yi4BKtsokj5fsy_mY8MybkTZHzSIAysBnMThi6gU_Ky6TNi1yyMIIZUddXfLwIl5_9D5fB5Wz2fVpd0mZH8ua3dSX_gyqcA1yxSvYfkB0GhRPwG_CFIyAMx7_CGD703db6Cu79tqysU4xd1JlqzIpArVOe0fe2ml12pbM2hERnU1dI1Rb21wC9Copzvam3MBQmpBblpmuka2ETial2XYK8xc7-KEoTbJrQdEUuSqpJQOG8bBuTu5dgWF40ZT1uXg-2pd41OoMANfxabcphXjgXG1G2N2Vu2h58KtdiuPEE93wxIeDK7PfdhypcPqZUHSlt0rwAnFUemZrowf5GE555U2Nq2sHsGXmT19H4pioeH4MlCXx6LeB0vdWoezHHWlx_nO-GLMT-rzvkwAMnw5mTg-Ts-Piin8nDIOZuvxKO5Za_PhE7SXdj_Cxr9nyVvXV2LV9W98m9zu-giSHRAzJT1UNymFSirbff6FuqM4H1EsshyTSvaMcrekrhoHlFgVd05BXteUUHXtG2pgOv6MgrOvKKIq8ekdXZ-9XJ0u724rAl41FrZ6DkHVnkTp4VbsRi5QrXlTGLwyIOcgFCMlSMB4KBBx4ILlgsuHZenczzVcYek3kFFH1KqCyiCNvVexFXPi-8WIIVCXOuYl84TPgL4vRvMpVdn3rcLmWTDh22NQ4p4JAiDilfkHfDLdemScufLn7dw5OCKcX1MVEp4H7qOTpawLx4QZ4Y3IbhepwXxOqBTDtL0Nz-rGe3jvOc3B2_kBdk3n7ZqZcgb9vsVcfCH0EdonE |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+vitamin+D+in+obese+and+overweight+subjects+according+to+estimated+glomerular+filtration+rate&rft.jtitle=Hormones+%28Athens%2C+Greece%29&rft.au=Kitsos%2C+Athanasios&rft.au=Dounousi%2C+Evangelia&rft.au=Kalaitzidis%2C+Rigas&rft.au=Challa%2C+Anna&rft.date=2018-06-01&rft.eissn=2520-8721&rft.volume=17&rft.issue=2&rft.spage=237&rft_id=info:doi/10.1007%2Fs42000-018-0022-8&rft_id=info%3Apmid%2F29858844&rft.externalDocID=29858844 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1109-3099&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1109-3099&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1109-3099&client=summon |